Surmodics EBITDA Margin 2010-2025 | SRDX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Surmodics (SRDX) over the last 10 years. The current EBITDA margin for Surmodics as of March 31, 2025 is .
| Surmodics EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.12B | $0.00B | -2.48% |
| 2024-12-31 | $0.13B | $0.00B | 1.60% |
| 2024-09-30 | $0.13B | $0.00B | 3.17% |
| 2024-06-30 | $0.12B | $0.00B | 1.65% |
| 2024-03-31 | $0.14B | $0.03B | 20.28% |
| 2023-12-31 | $0.14B | $0.02B | 15.94% |
| 2023-09-30 | $0.13B | $0.02B | 11.36% |
| 2023-06-30 | $0.13B | $0.01B | 8.46% |
| 2023-03-31 | $0.10B | $-0.02B | -17.48% |
| 2022-12-31 | $0.10B | $-0.02B | -16.67% |
| 2022-09-30 | $0.10B | $-0.01B | -13.00% |
| 2022-06-30 | $0.10B | $-0.01B | -7.14% |
| 2022-03-31 | $0.10B | $0.00B | -3.09% |
| 2021-12-31 | $0.11B | $0.01B | 10.38% |
| 2021-09-30 | $0.11B | $0.01B | 13.33% |
| 2021-06-30 | $0.10B | $0.01B | 11.54% |
| 2021-03-31 | $0.11B | $0.02B | 14.95% |
| 2020-12-31 | $0.10B | $0.01B | 7.37% |
| 2020-09-30 | $0.10B | $0.01B | 7.29% |
| 2020-06-30 | $0.10B | $0.01B | 12.50% |
| 2020-03-31 | $0.10B | $0.01B | 12.87% |
| 2019-12-31 | $0.10B | $0.01B | 13.86% |
| 2019-09-30 | $0.10B | $0.01B | 14.00% |
| 2019-06-30 | $0.09B | $0.01B | 7.61% |
| 2019-03-31 | $0.09B | $0.00B | -1.11% |
| 2018-12-31 | $0.09B | $0.00B | -2.33% |
| 2018-09-30 | $0.08B | $0.00B | -3.70% |
| 2018-06-30 | $0.08B | 0 | 0.00% |
| 2018-03-31 | $0.07B | $0.01B | 10.81% |
| 2017-12-31 | $0.07B | $0.01B | 12.33% |
| 2017-09-30 | $0.07B | $0.01B | 17.57% |
| 2017-06-30 | $0.07B | $0.02B | 22.22% |
| 2017-03-31 | $0.07B | $0.02B | 28.38% |
| 2016-12-31 | $0.07B | $0.02B | 30.14% |
| 2016-09-30 | $0.07B | $0.02B | 30.56% |
| 2016-06-30 | $0.07B | $0.02B | 30.99% |
| 2016-03-31 | $0.07B | $0.02B | 31.34% |
| 2015-12-31 | $0.06B | $0.02B | 34.38% |
| 2015-09-30 | $0.06B | $0.02B | 37.70% |
| 2015-06-30 | $0.06B | $0.02B | 40.68% |
| 2015-03-31 | $0.06B | $0.02B | 39.66% |
| 2014-12-31 | $0.06B | $0.02B | 37.93% |
| 2014-09-30 | $0.06B | $0.02B | 36.21% |
| 2014-06-30 | $0.06B | $0.02B | 36.84% |
| 2014-03-31 | $0.06B | $0.02B | 35.71% |
| 2013-12-31 | $0.06B | $0.02B | 37.50% |
| 2013-09-30 | $0.06B | $0.02B | 39.29% |
| 2013-06-30 | $0.06B | $0.02B | 37.50% |
| 2013-03-31 | $0.06B | $0.02B | 39.29% |
| 2012-12-31 | $0.05B | $0.02B | 38.89% |
| 2012-09-30 | $0.05B | $0.02B | 36.54% |
| 2012-06-30 | $0.05B | $0.02B | 34.62% |
| 2012-03-31 | $0.05B | $0.02B | 33.33% |
| 2011-12-31 | $0.05B | $0.02B | 34.62% |
| 2011-09-30 | $0.05B | $0.02B | 35.85% |
| 2011-06-30 | $0.06B | $0.00B | -9.09% |
| 2011-03-31 | $0.06B | $-0.01B | -9.84% |
| 2010-12-31 | $0.07B | $-0.01B | -15.15% |
| 2010-09-30 | $0.07B | $-0.01B | -14.29% |
| 2010-06-30 | $0.07B | $0.02B | 21.92% |
| 2010-03-31 | $0.07B | $0.02B | 25.00% |
| 2009-12-31 | $0.08B | $0.03B | 33.33% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.429B | $0.126B |
| Surmodics is a leading provider of medical device and In Vitro Diagnostics (IVD) technologies to the healthcare industry. It reports through two divisions: Medical Devices & IVD.?The Medical Devices segment comprises surface modification coating technologies to improve access, deliverability, and predictable deployment of medical devices, international cardiology and peripheral balloon design, development and manufacturing, as well as drug delivery coating technologies to provide site-specific drug delivery from the surface of a medical device, with end markets that include coronary, peripheral, neuro-vascular and urology, among others. The IVD segment includes component products and technologies for diagnostic test kits and biomedical research applications, with products that include protein stabilization reagents, substrates, antigens and surface coatings. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.904B | 28.13 |
| Boston Scientific (BSX) | United States | $154.336B | 38.64 |
| Stryker (SYK) | United States | $150.874B | 31.55 |
| EssilorLuxottica (ESLOY) | France | $127.819B | 0.00 |
| Medtronic (MDT) | Ireland | $113.364B | 16.07 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.609B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.066B | 26.28 |
| ResMed (RMD) | United States | $37.677B | 28.30 |
| GE HealthCare Technologies (GEHC) | United States | $34.831B | 16.54 |
| Agilent Technologies (A) | United States | $34.480B | 22.48 |
| Terumo (TRUMY) | Japan | $25.244B | 32.79 |
| Koninklijke Philips (PHG) | Netherlands | $23.274B | 16.33 |
| Insulet (PODD) | United States | $21.186B | 83.16 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.532B | 11.90 |
| Baxter (BAX) | United States | $15.914B | 11.88 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.262B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.846B | 23.82 |
| Lantheus Holdings (LNTH) | United States | $5.564B | 14.03 |
| Prestige Consumer Healthcare (PBH) | United States | $3.952B | 17.66 |
| Perrigo (PRGO) | Ireland | $3.739B | 9.48 |
| Haemonetics (HAE) | United States | $3.693B | 16.82 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.456B | 28.72 |
| ICU Medical (ICUI) | United States | $3.333B | 24.58 |
| QuidelOrtho (QDEL) | United States | $2.042B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.907B | 42.62 |
| AtriCure (ATRC) | United States | $1.572B | 0.00 |
| Acuren (TIC) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.258B | 12.77 |
| Green Thumb Industries (GTBIF) | United States | $1.164B | 26.19 |
| Neogen (NEOG) | United States | $1.157B | 14.81 |
| Phibro Animal Health (PAHC) | United States | $1.135B | 14.51 |
| BioLife Solutions (BLFS) | United States | $1.085B | 0.00 |
| InMode (INMD) | Israel | $0.958B | 9.66 |
| Kestra Medical Technologies (KMTS) | United States | $0.805B | 0.00 |
| Owens & Minor (OMI) | United States | $0.712B | 5.90 |
| CeriBell (CBLL) | United States | $0.684B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.680B | 0.00 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.555B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.542B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.468B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.363B | 13.33 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| Quanterix (QTRX) | United States | $0.349B | 0.00 |
| SNDL (SNDL) | Canada | $0.334B | 0.00 |
| Cerus (CERS) | United States | $0.294B | 0.00 |
| ZimVie (ZIMV) | United States | $0.285B | 12.97 |
| Viemed Healthcare (VMD) | United States | $0.283B | 23.83 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.264B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 75.67 |
| Brainsway (BWAY) | Israel | $0.250B | 66.20 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.231B | 6.49 |
| OraSure Technologies (OSUR) | United States | $0.230B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.192B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.190B | 15.46 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.150B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 16.35 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.48 |
| MacroGenics (MGNX) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.089B | 0.00 |
| Apyx Medical (APYX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.084B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.57 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.86 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |